Cargando…
Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders
Recently standardized diagnostic instruments have been developed in diagnostic and therapeutic procedures for Autism Spectrumv Disorders (ASD). According to the DSM-5 criteria, individuals with ASD must show symptoms from early childhood. These symptoms are communication deficits and restricted, rep...
Autores principales: | Santini, Annamaria Chiara, Pierantoni, Giovanna Maria, Gerlini, Raffaele, Iorio, Rosamaria, Olabinjo, Yinka, Giovane, Alfonso, Di Domenico, Marina, Sogos, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925524/ https://www.ncbi.nlm.nih.gov/pubmed/24605324 http://dx.doi.org/10.1155/2014/234295 |
Ejemplares similares
-
Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022) -
GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
por: El-Ansary, Afaf, et al.
Publicado: (2014) -
Behavioral gender differences across Pre-School Children with Autism Spectrum Disorders: a cross-sectional study
por: Tofani, Marco, et al.
Publicado: (2022) -
The State of the Dopaminergic and Glutamatergic Systems in the Valproic Acid Mouse Model of Autism Spectrum Disorder
por: Maisterrena, Alexandre, et al.
Publicado: (2022) -
A wearable heart rate measurement device for children with autism spectrum disorder
por: Fioriello, Francesca, et al.
Publicado: (2020)